BRCA1 and breast carcinoma: In addition, Peroxisome proliferator-activated receptor gamma (PPARγ) was overexpressed in BRCA1-defective breast cancer patients, and in vascular smooth muscle cells PPARγ was found to regulate PFKP [49, 50].